Loading…
BioRestorative Therapies, Inc. is projected to decline to $0.1776 by 2027, a -10% move from its current price of $0.1979. BRTX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.1881 | $0.1977 | $0.2079 | -0.08% |
| Aug 6 | $0.184 | $0.1976 | $0.2121 | -0.17% |
| Aug 7 | $0.181 | $0.1974 | $0.2153 | -0.25% |
| Aug 8 | $0.1784 | $0.1972 | $0.218 | -0.34% |
| Aug 9 | $0.1762 | $0.1971 | $0.2205 | -0.42% |
| Aug 10 | $0.1741 | $0.1969 | $0.2226 | -0.50% |
| Aug 11 | $0.1723 | $0.1967 | $0.2247 | -0.59% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.1723 | $0.1967 | $0.2247 | -0.59% |
| Week 2 | $0.1621 | $0.1956 | $0.236 | -1.17% |
| Week 3 | $0.1545 | $0.1944 | $0.2447 | -1.75% |
| Week 4 | $0.1482 | $0.1933 | $0.252 | -2.33% |
| Week 5 | $0.1428 | $0.1922 | $0.2585 | -2.90% |
| Week 6 | $0.138 | $0.191 | $0.2644 | -3.47% |
| Week 7 | $0.1337 | $0.1899 | $0.2698 | -4.04% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. The company develops programs related to the treatment of disc/spine disease and metabolic disorders.
Its products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, as well as used for the non-surgical treatment of painful lumbosacral disc disorders or as a complimentary therapeutic to a surgical procedure; and ThermoStem, a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. The company also operates a commercial biocosmeceutical platform. In addition, it provides investigational curved needle device to deliver cells and/or other therapeutic products or material to the spine and discs, and other parts of the body.
The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. is headquartered in Melville, New York.
BioRestorative Therapies, Inc. (BRTX) is a Healthcare company with a current price of $0.2047 and a market cap of $5.22M. It is ranked 5268 in market capitalization. The stock trades in a micro-cap range and is characterized by a modest price level relative to larger peers.
A major floor 65.6% below — a decisive break under it would weaken the trend.
Support has flipped 3.4% overhead — reclaiming it would be bullish.
The nearest ceiling, 107.0% above — a clean break opens room to run.
A major ceiling 142.0% above — clearing it would confirm fresh momentum.
Key BRTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BRTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.2442 | Sell | $0.2405 | Sell |
| MA 10 | $0.2785 | Sell | $0.2688 | Sell |
| MA 20 | $0.314 | Sell | $0.30 | Sell |
| MA 50 | $0.3463 | Sell | $0.3249 | Sell |
| MA 100 | $0.2974 | Sell | $0.3983 | Sell |
| MA 200 | $0.6773 | Sell | $0.6367 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 22.36 | Buy |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -194.39 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -39.79 | Sell |
| Bollinger %B (20,2) | -0.08 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.78 | Sell |
| Awesome (5,34) | -0.10 | Sell |
| Ultimate (7,14,28) | 6.26 | Buy |
| Momentum (10) | -0.13 | Sell |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 0.21 | Sell |
| ADX (14) | 23.88 | Sell |
| ATR (14) | 0.01 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 20. The 50-day simple moving average is $0.3463 and the 200-day simple moving average is $0.6773. Support sits at $0.2047 and resistance at $0.4096, framing a near-term volatility boundary. The 30-day price range is $0.1471 to $0.2849, and annualized volatility is 100.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.1698 | $0.1979 | $0.2605 | 0% | Neutral | |
| $0.131 | $0.1776 | $0.2599 | -10% | Neutral | |
| $0.1252 | $0.1798 | $0.2799 | -9% | Neutral | |
| $0.166 | $0.2502 | $0.4083 | +26% | Bullish | |
| $0.1579 | $0.2486 | $0.4219 | +26% | Bullish | |
| $0.1555 | $0.2549 | $0.4472 | +29% | Bullish | |
| $0.1493 | $0.2545 | $0.4598 | +29% | Bullish | |
| $0.1094 | $0.1933 | $0.3588 | -2% | Neutral | |
| $0.1215 | $0.2226 | $0.4233 | +13% | Neutral | |
| $0.149 | $0.2827 | $0.5495 | +43% | Bullish | |
| $0.1385 | $0.3077 | $0.6555 | +55% | Bullish | |
| $0.3189 | $0.7087 | $1.63 | +258% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.1698 | $0.1979 | $0.2507 | +0.00% |
| September 2026 | $0.1613 | $0.1954 | $0.2466 | -1.25% |
| October 2026 | $0.1494 | $0.1833 | $0.2357 | -6.21% |
| November 2026 | $0.1532 | $0.19 | $0.2481 | +3.67% |
| December 2026 | $0.1571 | $0.1968 | $0.2605 | +3.57% |
Click any year to see its month-by-month BRTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, BRTX is projected to trade between $0.1698 and $0.2605, averaging $0.1979 — a potential gain of 0% from today's $0.1979. A consolidation phase looks the most probable path here.
BioRestorative Therapies, Inc.'s 2027 outlook centres on $0.1776, within a $0.131 to $0.2599 range. That is -10% versus the projected 2026 average. That marks a -10% change versus current levels. Price action looks broadly range-bound.
By 2028, BRTX could reach as high as $0.2799, with a base case around $0.1798 and support toward $0.1252 — roughly -9% from $0.1979. A consolidation phase looks the most probable path here.
Expect BRTX to range from $0.166 to $0.4083 through 2029. The $0.2502 average target implies a +26% move from current prices. That is up +39% on the projected 2028 average. Momentum favours further upside here.
The BRTX price prediction for 2030 points to an average of $0.2486 (low $0.1579, high $0.4219) — a potential gain of +26% on today's $0.1979. Buyers look set to stay in control over this stretch.
In 2031, BRTX is projected to trade between $0.1555 and $0.4472, averaging $0.2549 — a potential gain of +29% from today's $0.1979. That is up +3% on the projected 2030 average. Momentum favours further upside here.
BioRestorative Therapies, Inc.'s 2032 outlook centres on $0.2545, within a $0.1493 to $0.4598 range. That is 0% versus the projected 2031 average. That marks a +29% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, BRTX could reach as high as $0.3588, with a base case around $0.1933 and support toward $0.1094 — roughly -2% from $0.1979. Price action looks broadly range-bound.
Expect BRTX to range from $0.1215 to $0.4233 through 2034. The $0.2226 average target implies a +13% move from current prices. That is up +15% on the projected 2033 average. A consolidation phase looks the most probable path here.
The BRTX price prediction for 2035 points to an average of $0.2827 (low $0.149, high $0.5495) — a potential gain of +43% on today's $0.1979. Momentum favours further upside here.
In 2040, BRTX is projected to trade between $0.1385 and $0.6555, averaging $0.3077 — a potential gain of +55% from today's $0.1979. That is up +9% on the projected 2035 average. Buyers look set to stay in control over this stretch.
BioRestorative Therapies, Inc.'s 2050 outlook centres on $0.7087, within a $0.3189 to $1.63 range. That is up +130% on the projected 2040 average. That marks a +258% change versus current levels. Momentum favours further upside here.
Investing $1,000 in BRTX today (≈ 5,053.0571 BRTX) could be worth
$3,581.29
+$2,581.29 (+258%) by 2050 · US Dollar
Based on the average projected BRTX price of $0.71 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BRTXwould be worth at today's price.
$1,000 invested in BRTX on Jul 31, 2025 (≈ 680.272096 BRTX) would be worth
$134.63
-$865.37 (-86.5%) today · 0.13× · US Dollar
Based on a BRTX entry price of $1.47 vs. today's $0.1979.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.29 | $682.41 | -31.8% |
| 1 month ago | $0.3856 | $513.23 | -48.7% |
| 3 months ago | $0.2333 | $848.26 | -15.2% |
| 6 months ago | $1.15 | $172.09 | -82.8% |
| 1 year ago | $1.47 | $134.63 | -86.5% |
| All time (5.0y) ago | $18.4 | $10.76 | -98.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BRTX forecast.
Our base-case forecast reaches $0.40 around 2050.
Implied market cap at $0.40: $10.19M
The multi-year forecast shows a path of gradual appreciation with several bullish years. In 2029, the avg price is $0.2587, with a min of $0.1716, a max of $0.4222 and a ROI of 26.4% as sentiment is BULLISH. For 2030, the min is $0.1633, the avg is $0.2571, the max is $0.4363, and the ROI is 25.6% with a BULLISH sentiment.
In 2031, min $0.161, avg $0.2639, max $0.4631, ROI 28.9 and BULLISH sentiment, followed by 2032 with min $0.1542, avg $0.2628, max $0.475 and ROI 28.4 with BULLISH sentiment.
Tap a question to reveal the answer.
For 2030, the forecast lists min $0.1633, avg $0.2571, max $0.4363, ROI 25.6%, sentiment BULLISH.
Near term (2026-2028) shows NEUTRAL sentiment with 2026 avg $0.2047 and ROI 0%, 2027 ROI -10.3%, 2028 ROI -9%. Long term shows continued bullish momentum from 2029 onward, with ROIs of 26.4% (2029) and higher through 2050, but these are estimates and not guarantees.
Yes—the 2050 forecast lists a max of $1.68, indicating a path that could exceed $1 at its upper bound in the long-range projection.
The 2035 forecast shows min $0.1541, avg $0.2924, max $0.5685 with ROI 42.9 and sentiment BULLISH.
Current price is $0.2047 and market cap is $5.22M.
BioRestorative Therapies, Inc. Community Discussion
0Share your BioRestorative Therapies, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.